Literature for peptidase A01.007: renin

(References are filtered for relevance to Structure. To remove the filter click here. See explanation.)

2019
1. Yan,Y., Zhou,A., Carrell,R.W. and Read,R.J.
   Structural basis for the specificity of renin-mediated angiotensinogen cleavage
   J Biol Chem294, 2353-2364. PubMed  Europe PubMed DOI  S
2012
2. Morales,R., Watier,Y. and Bocskei,Z.
   Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor
   J Mol Biol421, 100-111. PubMed  Europe PubMed DOI  S
2003
3. [YEAR:5-9-2003]Wood,J.M., Maibaum,J., Rahuel,J., Grutter,M.G., Cohen,N.C., Rasetti,V., Ruger,H., Goschke,R., Stutz,S., Fuhrer,W., Schilling,W., Rigollier,P., Yamaguchi,Y., Cumin,F., Baum,H.P., Schnell,C.R., Herold,P., Mah,R., Jensen,C., O'Brien,E., Stanton,A. and Bedigian,M.P.
   Structure-based design of aliskiren, a novel orally effective renin inhibitor
   Biochem Biophys Res Commun308, 698-705. PubMed  Europe PubMed DOI  S  I
1996
4. Mathews,S., Dobeli,H., Pruschy,M., Bosser,R., D'arcy,A., Oefner,C., Zulauf,M., Gentz,R., Breu,V., Matile,H., Schlaeger,J. and Fischli,W.
   Recombinant human renin produced in different expression systems: biochemical properties and 3D structure
   Protein Expr Purif7, 81-91. PubMed  Europe PubMed DOI  E  S  I
1995
5. Tong,L., Pav,S., Lamarre,D., Simoneau,B., Lavallee,P. and Jung,G.
   Crystallographic studies on the binding modes of P2-P3 butanediamide renin inhibitors
   J Biol Chem270, 29520-29524. PubMed  Europe PubMed DOI  S  I
6. Tong,L., Pav,S., Lamarre,D., Pilote,L., Laplante,S., Anderson,P.C. and Jung,G.
   High resolution crystal structures of recombinant human renin in complex with polyhydroxymonoamide inhibitors
   J Mol Biol250, 211-222. PubMed  Europe PubMed DOI  S  I
1992
7. Dhanaraj,V., Dealwis,C.G., Frazao,C., Badasso,M., Sibanda,B.L., Tickle,I.J., Cooper,J.B., Driessen,H.P.C., Newman,M., Aguilar,C., Wood,S.P., Blundell,T.L., Hobart,P.M., Geoghegan,K.F., Ammirati,M.J., Danley,D.E., O'Connor,B.A. and Hoover,D.J.
   X-ray analyses of peptide-inhibitor complexes define the structural basis of specificity for human and mouse renins
   Nature357, 466-472. PubMed  Europe PubMed DOI  S
1991
8. Doi,M., In,Y., Inoue,M., Ishida,T., Iizuka,K., Akahane,K., Harada,H., Umeyama,H. and Kiso,Y.
   Conformational study of a potent human renin inhibitor: X-ray crystal structure of isopropyl (2R,3S)-4-cyclohexyl- 2- hydroxy-3-{N-[(2R)-2-morpholinocarbonylmethyl-3-(1- naphthyl)propionyl]-L-histidylamino}butyrate (KRI-1314), a pentapeptide analogue with amino acid sequence corresponding to the cleavage site of angiotensinogen
   Chem Soc J [Perkin 1]1991, 1153-1158.  S  I
9. Rahuel,J., Priestle,J.P. and Grutter,M.G.
   The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor
   J Struct Biol107, 227-236. PubMed  Europe PubMed  S  I
1990
10. Shiratori,Y., Nakagawa,S., Hori,H., Murakami,K. and Umeyama,H.
    Protein modeling of human prorenin using the molecular dynamics method
    J Mol Graph8, 163-167. PubMed  Europe PubMed  S